188 related articles for article (PubMed ID: 34182874)
21. Hydroxychloroquine as an anti-thrombotic in antiphospholipid syndrome.
Belizna C
Autoimmun Rev; 2015 Apr; 14(4):358-62. PubMed ID: 25534016
[TBL] [Abstract][Full Text] [Related]
22. Hydroxychloroquine in the primary thrombosis prophylaxis of antiphospholipid antibody positive patients without systemic autoimmune disease.
Erkan D; Unlu O; Sciascia S; Belmont HM; Branch DW; Cuadrado MJ; Gonzalez E; Knight JS; Uthman I; Willis R; Zhang Z; Wahl D; Zuily S; Tektonidou MG;
Lupus; 2018 Mar; 27(3):399-406. PubMed ID: 28764618
[TBL] [Abstract][Full Text] [Related]
23. The effect of hydroxychloroquine on thrombosis prevention and antiphospholipid antibody levels in primary antiphospholipid syndrome: A pilot open label randomized prospective study.
Kravvariti E; Koutsogianni A; Samoli E; Sfikakis PP; Tektonidou MG
Autoimmun Rev; 2020 Apr; 19(4):102491. PubMed ID: 32084592
[TBL] [Abstract][Full Text] [Related]
24. Is there any role for the hydroxychloroquine (HCQ) in refractory obstetrical antiphospholipid syndrome (APS) treatment?
De Carolis S; Botta A; Salvi S; di Pasquo E; Del Sordo G; Garufi C; Lanzone A; De Carolis MP
Autoimmun Rev; 2015 Sep; 14(9):760-2. PubMed ID: 25936295
[TBL] [Abstract][Full Text] [Related]
25. Hydroxychloroquine protects the annexin A5 anticoagulant shield from disruption by antiphospholipid antibodies: evidence for a novel effect for an old antimalarial drug.
Rand JH; Wu XX; Quinn AS; Ashton AW; Chen PP; Hathcock JJ; Andree HA; Taatjes DJ
Blood; 2010 Mar; 115(11):2292-9. PubMed ID: 19965621
[TBL] [Abstract][Full Text] [Related]
26. Hydroxychloroquine reverses the prothrombotic state in a mouse model of antiphospholipid syndrome: Role of reduced inflammation and endothelial dysfunction.
Miranda S; Billoir P; Damian L; Thiebaut PA; Schapman D; Le Besnerais M; Jouen F; Galas L; Levesque H; Le Cam-Duchez V; Joannides R; Richard V; Benhamou Y
PLoS One; 2019; 14(3):e0212614. PubMed ID: 30870459
[TBL] [Abstract][Full Text] [Related]
27. Decreased expression of heparin-binding epidermal growth factor-like growth factor as a newly identified pathogenic mechanism of antiphospholipid-mediated defective placentation.
Di Simone N; Marana R; Castellani R; Di Nicuolo F; D'Alessio MC; Raschi E; Borghi MO; Chen PP; Sanguinetti M; Caruso A; Meroni PL
Arthritis Rheum; 2010 May; 62(5):1504-12. PubMed ID: 20131286
[TBL] [Abstract][Full Text] [Related]
28. Modulation of trophoblast angiogenic factor secretion by antiphospholipid antibodies is not reversed by heparin.
Carroll TY; Mulla MJ; Han CS; Brosens JJ; Chamley LW; Giles I; Pericleous C; Rahman A; Sfakianaki AK; Paidas MJ; Abrahams VM
Am J Reprod Immunol; 2011 Oct; 66(4):286-96. PubMed ID: 21545366
[TBL] [Abstract][Full Text] [Related]
29. Amniotic fluid antiphospholipid antibodies: potential role in antiphospholipid syndrome-independent aberrant implantation process.
Bruno V; Nuccetelli M; Ticconi C; Bruno A; Martelli F; Capogna MV; Bernardini S; Piccione E; Pietropolli A
Reprod Biol Endocrinol; 2019 Oct; 17(1):79. PubMed ID: 31615575
[TBL] [Abstract][Full Text] [Related]
30. Can hydroxychloroquine be protective against COVID-19-associated thrombotic events ?
Devaux CA; Camoin-Jau L; Mege JL; Raoult D
J Microbiol Immunol Infect; 2021 Feb; 54(1):37-45. PubMed ID: 33500211
[TBL] [Abstract][Full Text] [Related]
31. Pravastatin does not prevent antiphospholipid antibody-mediated changes in human first trimester trophoblast function.
Odiari EA; Mulla MJ; Sfakianaki AK; Paidas MJ; Stanwood NL; Gariepy A; Brosens JJ; Chamley LW; Abrahams VM
Hum Reprod; 2012 Oct; 27(10):2933-40. PubMed ID: 22888169
[TBL] [Abstract][Full Text] [Related]
32. Hydroxychloroquine and antiphospholipid antibody-related pregnancy morbidity: a systematic review and meta-analysis.
Frishman M; Radin M; Schreiber K
Curr Opin Obstet Gynecol; 2020 Oct; 32(5):351-358. PubMed ID: 32675702
[TBL] [Abstract][Full Text] [Related]
33. Current insights in obstetric antiphospholipid syndrome.
Schreiber K; Radin M; Sciascia S
Curr Opin Obstet Gynecol; 2017 Dec; 29(6):397-403. PubMed ID: 28915160
[TBL] [Abstract][Full Text] [Related]
34. Effects of antibodies against human parvovirus B19 on angiogenic signaling.
Su CC; Hsu TC; Hsiao CH; Chiu CC; Tzang BS
Mol Med Rep; 2020 Mar; 21(3):1320-1327. PubMed ID: 31922220
[TBL] [Abstract][Full Text] [Related]
35. SAMD1 attenuates antiphospholipid syndrome-induced vascular injury and pregnancy complications.
An R; Yang Y; Liu L; Li P
Immun Inflamm Dis; 2022 Sep; 10(9):e678. PubMed ID: 36039649
[TBL] [Abstract][Full Text] [Related]
36. Risk factors for early severe preeclampsia in obstetric antiphospholipid syndrome with conventional treatment. The impact of hydroxychloroquine.
Latino JO; Udry S; Aranda F; Wingeyer SP; Romero DSF; Belizna C; Larrañaga G
Lupus; 2020 Nov; 29(13):1736-1742. PubMed ID: 32838621
[TBL] [Abstract][Full Text] [Related]
37. The impact of hydroxychloroquine on obstetric outcomes in refractory obstetric antiphospholipid syndrome.
Gerde M; Ibarra E; Mac Kenzie R; Fernandez Suarez C; Heer C; Alvarez R; Iglesias M; Balparda J; Beruti E; Rubinstein F
Thromb Res; 2021 Oct; 206():104-110. PubMed ID: 34454240
[TBL] [Abstract][Full Text] [Related]
38. Antiphospholipid antibodies and the placenta: a systematic review of their in vitro effects and modulation by treatment.
Tong M; Viall CA; Chamley LW
Hum Reprod Update; 2015; 21(1):97-118. PubMed ID: 25228006
[TBL] [Abstract][Full Text] [Related]
39. Antiphospholipid antibody-induced miR-146a-3p drives trophoblast interleukin-8 secretion through activation of Toll-like receptor 8.
Gysler SM; Mulla MJ; Guerra M; Brosens JJ; Salmon JE; Chamley LW; Abrahams VM
Mol Hum Reprod; 2016 Jul; 22(7):465-74. PubMed ID: 27029214
[TBL] [Abstract][Full Text] [Related]
40. Antiphospholipid syndrome: a comprehensive review of a complex and multisystemic disease.
Palomo I; Segovia F; Ortega C; Pierangeli S
Clin Exp Rheumatol; 2009; 27(4):668-77. PubMed ID: 19772805
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
